Abstract: A vehicle indoor illumination device includes a housing having an upper opening with an internal space formed therein, a light-emitting unit disposed on the housing to emit light, a diffuser disposed outside the light-emitting unit in a manner as to close the upper opening of the housing to allow the light emitted from the light-emitting unit to diffuse to the outside, a cover part disposed on an outer surface of the diffuser and on which a light pattern is formed through scattering of the light transmitted through the diffuser, and a controller configured to receive an operation signal of a vehicle electronic part to control an operation of the light-emitting unit.

Abstract: The present invention relates to a technology for analyzing and detecting/diagnosing a target nucleic acid. When the detection system according to the present invention is used, effective real-time detection or diagnosis efficiency can be obtained while problems such as noise are minimized. In particular, since, by using a house-keeping gene according to a method of use, the expression difference of the target nucleic acid can be corrected, and direct real-time target nucleic acid detection is possible, it can be effectively used for detecting various nucleic acids and diagnosing various diseases thereby.

Abstract: A vehicle indoor illumination device includes a housing having an upper opening with an internal space formed therein, a light-emitting unit disposed on the housing to emit light, a diffuser disposed outside the light-emitting unit in a manner as to close the upper opening of the housing to allow the light emitted from the light-emitting unit to diffuse to the outside, a cover part disposed on an outer surface of the diffuser and on which a light pattern is formed through scattering of the light transmitted through the diffuser, and a controller configured to receive an operation signal of a vehicle electronic part to control an operation of the light-emitting unit.

Abstract: The present disclosure provides a reagent composition for detecting illicit drugs, the composition comprising: a diacetylene derivative compound represented by chemical formula 1; and at least one compound selected from among gabazine (SR-95531), an amine group-linked diacetylene derivative represented by chemical formula 2-1, and a gabazine-linked diacetylene derivative represented by chemical formula 2-2.

Abstract: The present invention provides a target RNA detection method based on a dCas9/gRNA complex. A target RNA detection method according to the present invention can detect target RNA with the naked eye and without separate gene isolation and amplification steps, and, in particular, can rapidly and accurately detect target RNA through excellent target specificity and rapidity, and thus can exhibit excellent effects on the detection of various pathogens and/or viruses.

Abstract: The present invention relates to a pharmaceutical composition, a health functional food, and a feed composition for the prevention, improvement, or treatment of non-alcoholic liver disease or insulin resistance comprising ginsenoside F2. The pharmaceutical composition according to the present invention comprising ginsenoside F2 can inhibit the adipogenesis and lipid accumulation in the liver, improve insulin sensitivity, inhibit the expression of inflammatory cytokines such as TNF-?, IL-?, and IL-6 in the Kupffer cell, inhibit the expression of endocannabinoid synthase, thus capable of effectively preventing or treating non-alcoholic liver disease or insulin resistance.

Abstract: Disclosed is a novel compound, and a cosmetic composition for whitening and a pharmaceutical composition for preventing and treating a melanin hyperpigmentation disorder by activating autophagy to induce melanosome degradation and also by effectively inhibiting endocytosis of keratinocytes to interfere melanosome transfer into keratinocytes, thereby expressing an excellent effect on improvement, prevention, and treatment of a hyperpigmentation disorder induced from melanin.

Abstract: Disclosed is a novel compound, and a cosmetic composition for whitening and a pharmaceutical composition for preventing and treating a melanin hyperpigmentation disorder by activating autophagy to induce melanosome degradation and also by effectively inhibiting endocytosis of keratinocytes to interfere melanosome transfer into keratinocytes, thereby expressing an excellent effect on improvement, prevention, and treatment of a hyperpigmentation disorder induced from melanin.

Abstract: Provided are a cosmetic composition for anti-aging or alleviating skin redness, and a medicinal composition for treating and preventing skin inflammatory diseases caused by light, containing a compound inducing an increase in expression of adiponectin or a pharmaceutically acceptable salt thereof.

Abstract: Disclosed are an organic compound represented by formula 1, an organic optoelectric diode applying the organic compound, and a display device comprising the organic optoelectric diode.

Abstract: A method is disclosed for analyzing single nucleotide polymorphisms (SNPs) of mitochondrial DNA (mtDNA) using a peptide nucleic acid (PNA) probe and a melting curve analysis, and more particularly, a method is disclosed for analyzing SNPs of mtDNA by the melting curve analysis of a PNA probe and mtDNA, in which the PNA probe is coupled with a reporter and a quencher. By using PNA probes labeled with a reporter and a quencher in the method for analyzing SNPs of mtDNA, the time and cost required for individual identification can be drastically decreased, initial analysis can be carried out in the event of a large number of inspections or mass casualties, and human identification information can be coded, and thus the method is very easy to manage and supervise.

Abstract: Provided are a cosmetic composition for anti-aging or alleviating skin redness, and a medicinal composition for treating and preventing skin inflammatory diseases caused by light, containing a compound inducing an increase in expression of adiponectin or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a method for analyzing single nucleotide polymorphism (SNP) of mitochondrial DNA (mtDNA) using a peptide nucleic acid (PNA) probe and a melting curve analysis and more particularly, to a method for analyzing SNP of mtDNA by the melting curve analysis of a PNA probe and mtDNA using the PNA probe coupled with a reporter and a quencher. According to the present invention, the method for analyzing SNP of mtDNA uses PNA probes labeled with the reporter and the quencher so that time and cost required for individual identification can be drastically decreased, initial analysis can be carried out in the event of a large number of inspections or mass casualties, and human identification information can be coded, and thus it is very easy to manage and supervise the same.

Abstract: Provided is Youngia denticulata extract being effective for prevention and treatment of diseases caused by an environmental pollution substance, and capable of protecting cell damage.

Abstract: A compound represented by Chemical Formula 1, an organic optoelectronic device including the same, and a display device including the organic optoelectronic device are provided. The structure of the compound represented by Chemical Formula 1 is described in the present specification.

Abstract: Disclosed are an organic compound represented by formula 1, an organic optoelectric diode applying the organic compound, and a display device comprising the organic optoelectric diode.

Abstract: The present invention relates to a pharmaceutical composition, a health functional food, and a feed composition for the prevention, improvement, or treatment of non-alcoholic liver disease or insulin resistance comprising ginsenoside F2. The pharmaceutical composition according to the present invention comprising ginsenoside F2 can inhibit the adipogenesis and lipid accumulation in the liver, improve insulin sensitivity, inhibit the expression of inflammatory cytokines such as TNF-?, IL-?, and IL-6 in the Kupffer cell, inhibit the expression of endocannabinoid synthase, thus capable of effectively preventing or treating non-alcoholic liver disease or insulin resistance.

Abstract: A compound represented by Chemical Formula 1, an organic optoelectronic device including the same, and a display device including the organic optoelectronic device are provided. The structure of the compound represented by Chemical Formula 1 is described in the present specification.

Abstract: Provided are use of ginsenoside F2 in the prevention, improvement or treatment of liver disease, and a pharmaceutical composition, a health functional food, and a feed composition including ginsenoside F2. Ginsenoside F2 inhibits fat synthesis and accumulation in the liver, and increases distribution of regulatory T cells capable of inhibiting activity of inflammatory cells, thereby preventing hepatitis, and also increases expression of anti-inflammatory cytokine IL-10 in regulatory T cells, and inhibits differentiation of naive T cells into Th17 cells, and is thereby effectively used for the treatment of various liver diseases.